Modulation of acetylcholine receptor by antibody against the receptor.
Antibody against acetylcholine receptor induces an increase in the rate of degradation of acetylcholine receptors on a mouse cell line (BC(3)H-1) and cultured rat skeletal muscle. The increased rate of degradation results in a lowered density of acetylcholine receptors on muscle membrane and a lowered sensitivity to iontophoretically applied acetylcholine. The modulation of acetylcholine receptor is energy, temperature, and time dependent and may be related to antigenic modulation found in other systems. Acetylcholine noise analysis demonstrates that antibody against acetylcholine receptor reduces the channel mean conductance and mean open time slightly. It is concluded that antibody binds to the acetylcholine receptor, impairs its function, and induces receptor degradation. This results in a lowered density of acetylcholine receptor and a lowered sensitivity to acetylcholine. Patients with myasthenia gravis have antibodies to their acetylcholine receptor in their serum. Antigenic modulation of receptor in the muscle of patients with myasthenia gravis could contribute to the observed decrease in amplitudes of miniature endplate potentials and in muscle acetylcholine sensitivity, and the symptoms of muscular weakness.
D000109:Acetylcholine / Q000494:pharmacology; D000906:Antibodies; D000937:Antigen-Antibody Reactions; D001665:Binding Sites; D002038:Bungarotoxins / Q000378:metabolism; D002478:Cells, Cultured; D004553:Electric Conductivity; D007700:Kinetics; D008564:Membrane Potentials / Q000187:drug effects; D009132:Muscles / Q000378:metabolism*; D009157:Myasthenia Gravis / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology* / Q000378:metabolism; D013696:Temperature
D000906:Antibodies; D002038:Bungarotoxins; D011950:Receptors, Cholinergic; D000109:Acetylcholine
J Physiol. 1964 Nov;174:417-34
14232401
J Physiol. 1964 Mar;170:389-96
14165174
Cell. 1977 Mar;10(3):365-73
844098
J Biol Chem. 1977 Mar 25;252(6):2143-53
845167
Nature. 1976 Nov 4;264(5581):74-6
1004540
Neurology. 1976 Nov;26(11):1054-9
988512
J Physiol. 1972 Aug;224(3):665-99
5071933
J Physiol. 1973 Dec;235(3):655-91
4543940
J Physiol. 1967 Jan;188(1):53-66
6040582
J Immunol. 1968 Jul;101(1):99-103
4173941
J Physiol. 1975 Nov;252(3):771-89
1206575
J Cell Biol. 1974 May;61(2):398-413
4363958
Proc Natl Acad Sci U S A. 1974 Jan;71(1):84-8
4359334
Nature. 1967 Sep 9;215(5106):1177-8
4294063
Proc Natl Acad Sci U S A. 1975 Sep;72(9):3735-9
1059161
Proc Natl Acad Sci U S A. 1975 May;72(5):1945-9
1057183
Lancet. 1975 Mar 15;1(7907):607-9
47950
Lancet. 1975 Aug 23;2(7930):340-2
51144
Proc Natl Acad Sci U S A. 1972 Nov;69(11):3180-4
4508312
Proc Natl Acad Sci U S A. 1972 Oct;69(10):2762-6
4507600
J Cell Biol. 1975 May;65(2):335-58
236319
J Exp Med. 1976 Sep 1;144(3):726-38
182896
Exp Neurol. 1976 Jun;51(3):536-63
179836
Biochemistry. 1975 Aug 26;14(17):3845-51
169886
Science. 1974 Oct 4;186(4158):55-7
4421998
Eur J Immunol. 1974 Nov;4(11):732-9
4426331
J Gen Physiol. 1973 Sep;62(3):255-70
4738329
Science. 1973 Oct 19;182(4109):293-5
4742736
Ann N Y Acad Sci. 1976;274:475-92
1066995
Ann N Y Acad Sci. 1976;274:300-18
1066990
Ann N Y Acad Sci. 1976;274:254-74
1066988
Proc Natl Acad Sci U S A. 1975 Jun;72(6):2140-4
1079601
Nature. 1976 Apr 1;260(5550):438-9
1256585
Biochemistry. 1975 May 20;14(10):2100-6
1148161
Nature. 1975 Feb 20;253(5493):643-4
1113859